Melania Dovizio

2.6k citations
63 papers · 2.0k indexed · h-index 25

Melania Dovizio

60 papers receiving 1.9k citations

Peers

Melania Dovizio
Comparison fields: 5 of 112
  • Pharmacology 557
  • Internal Medicine 116
  • Biochemistry 184
  • Sensory Systems 112
  • Cancer Research 316
Replace Seitaro Mutoh with:
Seitaro Mutoh Japan
Gert M. Kostner Austria
Denis deBlois Canada
Belay Tesfamariam United States
Fabiola Sinigaglia Italy
Adam C. Straub United States
Alexander Akhmedov Switzerland
Abu B. Al‐Mehdi United States
Guy C. Le Breton United States
Mukut Sharma United States
Melania Dovizio relative to Seitaro Mutoh Japan Seitaro Mutoh's profile →
Citations per field
00.5×5.9×
Seitaro Mutoh · 1×
Citations per year

Countries citing papers authored by Melania Dovizio

Since Specialization
Citations

This map shows the geographic impact of Melania Dovizio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melania Dovizio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melania Dovizio more than expected).

Fields of papers citing papers by Melania Dovizio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melania Dovizio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melania Dovizio. The network helps show where Melania Dovizio may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Melania Dovizio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melania Dovizio Line = papers co-authored together Melania Dovizio links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20256
2 20253
3 202415
4 20242
5 20243
6 20240
7 20230
8 20228
9 20216
10 202011
11 201928
12 201952
13 201850
14 201721
15 201472
16 201321
17 2012100
18 2011288
19 201017
20 200944

About Melania Dovizio

Melania Dovizio is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 63 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Eicosanoids and Hypertension Pharmacology (12 papers), Inflammatory Biomarkers in Disease Prognosis (10 papers), Estrogen and related hormone effects (5 papers), Extracellular vesicles in disease (4 papers), Platelet Disorders and Treatments (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Pharmacology (557 citations), Internal Medicine (116 citations) and Biochemistry (184 citations). Melania Dovizio has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Paola Patrignani, Annalisa Bruno, Stefania Tacconelli, Annalisa Contursi, Marco Caprini, Valentina Benfenati, Stefano Ferroni, Sara Alberti, Paloma Guillem‐Llobat and Rosalia Grande. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026